Strong order book but facing supply chain challenges
Getinge Q1 2022
Mattias Perjos, CEO
Lars Sandström, CFO
Key takeaways
Q1 2022
• Order intake and net sales impacted by challenging comps in ventilators
• Order book up 21% vs Q1 2021 (adj for FX)
• Net sales impacted by supply chain issues
• Margins impacted by volume, mix and supply chain challenges
• Free Cash Flow strengthened the financial position further
55
53.1
25,000
50
0
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
2520150
18.4
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
R12M Net Sales, MSEK
R12 Gross Margin (adj) %
R12 EBITA Margin (adj) %
Getinge │ Presentation │ Q1 Report 2022
April 26, 2022
Page 2
Key activities and events
Q1 2022
Offering and customers
Russian invasion and supply chain challenges
• Aquadis 56 - attractive offering for Ambulatory Care
• Limited exposure to Russia
• IN2 - modular room solutions for OR, ICU and CSSD
• Supply challenges impacting negatively
• Awarded a contract for anesthesia machines from
Sustainability improvements
Premier Inc, a leading US health care company
DPTE®-BetaBag capacity increase
• Life Science production sites are CO2 neutral since Jan 2022
• First deliveries took place from Merrimack, US, in the quarter
• Production volumes expected to increase gradually throughout the year
• Getinge's Anesthesia Automatic Gas Control shows 58% reduction in anesthetic wastage according to Journal of Clinical Monitoring and Computing
Getinge │ Presentation │ Q1 Report 2022
April 26, 2022
Page 3
Order intake and net sales impacted by challenging comps in ventilators
Supply chain challenges delaying net sales of approx. 300 MSEK
Global
Organic Order Growth -4.4%
Organic Net Sales Growth -6.4%
Getinge │ Presentation │ Q1 Report 2022
April 26, 2022
Page 4
Outlook 2022
Organic net sales growth is expected to be in the upper end of 4-6% for the full year
Getinge │ Presentation │ Q1 Report 2022
April 26, 2022
Page 5
Attachments
Original Link
Original Document
Permalink
Disclaimer
Getinge AB published this content on 25 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 April 2022 07:49:10 UTC.
Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows:
- medical systems (57.4%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.;
- hospital sterilization equipment (29.4%);
- contamination prevention equipment (13.2%): in the fields of biopharmaceutical production, biomedical research, manufacturing of medical devices and laboratory applications.
Net sales break down by source of income into sales of equipment (45.3%), consumables (37.1%), services and spare parts (17.6%).
At the end of 2021, the group had 20 production sites worldwide.
Net sales are distributed geographically as follows: Sweden (1.8%), Europe/Middle East/Africa (35.8%), Americas (37.9%) and Asia/Pacific (24.5%).
GETINGE AB 
